NCT Number: NCT02782000
The Model and Effect Assessment of Training General Practitioner for Dementia Early Recognition
With the number of aged people increasing and the lifespan lengthen, dementia is becoming a great public challenge in China. Early recognition of dementia is crucial to improve the prognosis of dementia patients and decrease the society disease burden. It is a pity that the early recognition rate of dementia is less than 7% in China. Most of the aged people live in the community and general practitioners (GP) in community provide health service much more frequently than other medical workers. It is suggested that GPs should be the best one to screen dementia in its early period. However, most of GPs have not receive any training about dementia early recognition in China. It is imperative and meaningful to provide training to GPs for improve GPs' knowledge and skills about dementia early recognition. How to train GPs for early recognizing dementia and how about the training effect? Which training model may be better? We did not find consistent conclusion about these questions in China. This study aims to set up an effective and convenient model to training GPs in dementia early recognition. A total of 152 GPs in Beijing will be enrolled and be randomly divided into two groups. One group will firstly have lessons about dementia early recognition and then receive face-to-face supervision and key messages by Wechat about dementia early recognition once a month in the following 6 months. Another group will firstly have lessons about dementia early recognition and then receive face-to-face supervision and key messages by Wechat about dementia early recognition once a month in the following 3 months. The score of knowledge and attitude about dementia early recognition, the accuracy of analyzing dementia cases, the usage of dementia screening scales and the referral rate of dementia will be evaluated at different time point respectively. This study will provide evidence for training GPs effectively in dementia early recognition in the future and will promote dementia early recognition in community.
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–60 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- General practitioner on-the-job and providing outpatient service
- Can complete the intervention and questionnaire;
- Providing informed consent voluntarily.
Exclusion criteria
- General practitioner who may take a long-term vacation during the study
- Providing less than once outpatient service every week;
- Having no condition to use Wechat;
- Refuse to join in this study.
Treatment and study plan
lessons,short-term supervision and message
OtherPrimary outcomes
-
Difference between the change of the score of knowledge about dementia early recognition from baseline to 7th month in the experimental group and that from baseline to 4th month in the active comparator group.
Time frame: up to 7 months
Secondary outcomes
-
Difference between the change of the score of attitude about dementia early recognition from baseline to 7th month in the experimental group and that from baseline to 4th month in the active comparator group.
Time frame: up to 7 months
-
Difference between the change of the accurate rate of analyzing dementia case from baseline to 7th month in the experimental group and that from baseline to 4th month in the active comparator group.
Time frame: up to 7 months
-
Difference between the number of the elderly screened by each general practitioner per month through the study in the experimental group and that in the active comparator group.
Time frame: up to 7 months
Sponsors and collaborators
Lead sponsor
Peking University Sixth Hospital
Other
Registry information
Important dates
- Study start
- 2016
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- May 25, 2016
- Registry last updated
- Dec 27, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsUniversity of Central Florida Music Study
NCT07306065
Alzheimer Disease, Alzheimers Disease
Orlando, Florida, United States
View Trial DetailsImpact of COVID-19 Vaccines on Cerebrovascular Health
NCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsCommunity-based Brain Health Program to Address Dementia Risk
NCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial Details